Medicines as a service a new commercial model for big pharma in the postblockbuster world
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the...
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Santa Monica, Calif. :
RAND
c2012.
|
| Edición: | 1st ed |
| Colección: | Occasional paper (Rand Corporation)
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009421479106719 |
| Sumario: | The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. |
|---|---|
| Notas: | Description based upon print version of record. |
| Descripción Física: | 1 online resource (12 p.) |
| Bibliografía: | Includes bibliographical references. |
| ISBN: | 9780833076465 |
